Healthcare

The Healthcare industry is facing incredible pressures to balance and address cost, quality and access. These pressures are driving our existing healthcare systems around the globe into a crisis. With the challenges of financial pressures, service demands, changing demographics, and chronic and infectious diseases many existing healthcare systems are reaching their breaking point. Key entities such as government, healthcare providers, healthcare insurers and patients’ perspectives must be reconciled and aligned.

Collaborative Software Initiative understands without collaboration a shared vision will not be created. Collaborative Software Initiative brings together like-minded entities that are open to the collaborative model (an open and inclusive process) to work together as subject matter experts to establish a collective vision, to determine the scope and priorities, to execute against the vision, to meet regularly, to guide the project, and to share the cost of the project amongst the group.

In showing the strength of our collaborative model in the area of public health, Collaborative Software Initiative has built CSI TriSano™. CSI TriSano™ is an open source, citizen-focused surveillance and outbreak management system for infectious disease, environmental hazards, and bioterrorism attacks. It allows local, state and federal entities to gather information through interactions with citizens and provides the transparency for public health officials to make a positive impact on the health and well being of their citizens. CSI TriSano™ is the outcome of a collaborative project with subject matter experts (i.e., doctors, nurses, epidemiologists and informaticists) working together with our program manager and development experts to deliver the next generation disease surveillance and outbreak management application.

Collaborative Software Initiative has also recently launched a project with like-minded pharmaceutical industry entities using the collaborative model to address the research and development (R&D) challenges they face. The pharmaceutical industry spends far more on R&D and produces far fewer new molecules than it did 20 years ago, with deteriorating financial performance. There is a shortage of good medicines and R&D faces a lack of productivity in the laboratories. Many of these entities are using the same or similar tools for R&D, by collaborating on new research tools and applications together they can save money, mitigate risk, speed innovation and reduce their application development time.

The innovations capable of addressing the specific challenges inherent in transforming healthcare will require collaboration. Collaborative Software Initiative is developing applications with subject matter experts who are passionate about solving their problems collaboratively, supported by our program managers and developers. If you would like to learn how your organization could benefit from the CSI collaborative process, please accept this invitation to join one of our existing core teams or lead one of your own.